Loading clinical trials...
Loading clinical trials...
During direct anterior approach (DAA) for total hip arthroplasty (THA), ligation of the lateral femoral circumflex artery and vessel is always conducted. However, this standardized procedure may jeopardize blood muscle perfusion and cause tenderness in the tensor fascia lata muscle. The investigators want to investigate whether blood vessel-sparing surgery is feasible, reproducible, and would alter outcomes following DAA THA. The surgical technique of the vessel-sparing procedure will be described and investigated in a prospective blinded RCT. The investigators hypothesize that the vessel-sparing technique is feasible in 60% of the patients. If these vessels were not sacrificed, the investigators expect the incidence of TFL tendinopathy to be lower.
Primary objective: to compare a group with successful vessel-sparing with a vessel-sacrificed-group for: 1. Incidence of TFL tendinopathy 2. Patient-reported outcomes 3. Component placement Secondary objective: to observe the feasibility of the vessel-sparing surgical technique. This is a monocentric prospective randomized blinded clinical trial during a period of minimum 3 years or until 150% of the sample size is included (100 patients).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
Start Date
June 11, 2024
Primary Completion Date
March 1, 2025
Completion Date
March 1, 2027
Last Updated
November 15, 2024
300
ESTIMATED participants
Vessel sparing technique
PROCEDURE
Vessel ligation technique
PROCEDURE
Lead Sponsor
Ziekenhuis Oost-Limburg
NCT06527664
NCT05216666
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions